Article thumbnail

Erythropoietin reduces neuronal cell death and hyperalgesia induced by peripheral inflammatory pain in neonatal rats

By Osama Mohamad, Dongdong Chen, Lingling Zhang, Cane Hofmann, Ling Wei and Shan Ping Yu

Abstract

Painful stimuli during neonatal stage may affect brain development and contribute to abnormal behaviors in adulthood. Very few specific therapies are available for this developmental disorder. A better understanding of the mechanisms and consequences of painful stimuli during the neonatal period is essential for the development of effective therapies. In this study, we examined brain reactions in a neonatal rat model of peripheral inflammatory pain. We focused on the inflammatory insult-induced brain responses and delayed changes in behavior and pain sensation. Postnatal day 3 pups received formalin injections into the paws once a day for 3 days. The insult induced dysregulation of several inflammatory factors in the brain and caused selective neuronal cell death in the cortex, hippocampus and hypothalamus. On postnatal day 21, rats that received the inflammatory nociceptive insult exhibited increased local cerebral blood flow in the somatosensory cortex, hyperalgesia, and decreased exploratory behaviors. Based on these observations, we tested recombinant human erythropoietin (rhEPO) as a potential treatment to prevent the inflammatory pain-induced changes. rhEPO treatment (5,000 U/kg/day, i.p.), coupled to formalin injections, ameliorated neuronal cell death and normalized the inflammatory response. Rats that received formalin plus rhEPO exhibited normal levels of cerebral blood flow, pain sensitivity and exploratory behavior. Treatment with rhEPO also restored normal brain and body weights that were reduced in the formalin group. These data suggest that severe inflammatory pain has adverse effects on brain development and rhEPO may be a possible therapy for the prevention and treatment of this developmental disorder

Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3161880
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1999). A: Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury.
  2. (2003). A: Kangaroo care is effective in diminishing pain response in preterm neonates. Arch Pediatr Adolesc Med
  3. (1991). AE: Erythropoietin in anemia of renal failure in sickle cell disease.
  4. (2006). Ahmadiani A: Nitric oxide and c-Jun N-terminal kinase are involved in the development of dark neurons induced by inflammatory pain. Synapse
  5. (1999). Alleviation of the pain of venepuncture in neonates. Acta Paediatr
  6. (2004). Apoptosis-inducing factor (AIF): caspase-independent after all. Cell Death Differ
  7. (1995). Apoptotic cells in the human endometrium and placental villi: pitfalls in applying the TUNEL method. Arch Histol Cytol
  8. Basbaum AI: Pain behavior in the formalin test persists after ablation of the great majority of Cfiber nociceptors.
  9. (1997). Biological barriers to paediatric pain management.
  10. (2002). BJ: Adverse effects of pain on the nervous systems of newborns and young children: a review of the literature.
  11. (2009). CC: The extremely premature neonate: anticipating and managing care. BMJ
  12. (1979). Comparative aspects of the brain growth spurt. Early Hum Dev
  13. (2002). Conditioning and hyperalgesia in newborns exposed to repeated heel lances. JAMA
  14. (2011). Covolan L: Long-term gender behavioral vulnerability after nociceptive neonatal formalin stimulation in rats. Neurosci Lett
  15. (2002). CT: Erythropoietin receptor signalling is required for normal brain development. Development
  16. (2005). DM: Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways.
  17. (1997). DW: Susceptibility to apoptosis is enhanced in immature cortical neurons. Brain Res
  18. (2002). Early pain in preterm infants A model of long-term effects. Clin Perinatol
  19. (1997). Effect of neonatal circumcision on pain response during subsequent routine vaccination. Lancet
  20. (2009). Effects of recombinant human erythropoietin on neuropathic pain and cerebral expressions of cytokines and nuclear factor-kappa B.
  21. (1997). Efficacy and safety of lidocaine-prilocaine cream for pain during circumcision.
  22. (1997). Einarson T: The efficacy of sucrose for relieving procedural pain in neonates–a systematic review and metaanalysis. Acta Paediatr
  23. Erythropoietin improves neurodevelopmental outcome of extremely preterm infants.
  24. (2001). Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA
  25. (2003). Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis.
  26. (2002). Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med
  27. (2007). Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice.
  28. (2003). Erythropoietin: physiology and pharmacology update. Exp Biol Med (Maywood)
  29. (2005). Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res
  30. (1985). Formalin test in mice, a useful technique for evaluating mild analgesics.
  31. (1994). Gebhart GF: Effects of neonatal capsaicin treatment on descending modulation of spinal nociception from the rostral, medial medulla in adult rat. Brain Res
  32. (2002). Grunau RE: Pain in vulnerable infants Introduction. Clin Perinatol
  33. (2009). Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants. Pediatrics
  34. (2005). Hof PR: Design-based stereology in neuroscience. Neuroscience
  35. (2005). Isenmann S: Erythropoietin promotes regeneration of adult CNS neurons via Jak2/Stat3 and PI3K/AKT pathway activation. Mol Cell Neurosci
  36. (1996). JA: Annual summary of vital statistics–1995. Pediatrics
  37. (1999). JW: Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science
  38. (2004). KG: Neurodevelopmental outcome and growth at 18 to 22 months’ corrected age in extremely low birth weight infants treated with early erythropoietin and iron. Pediatrics
  39. (1999). Management of pain from heel lance with lidocaine-prilocaine (EMLA) cream: is it safe and efficacious in preterm infants? J Dev Behav Pediatr
  40. (2007). Nuyt AM: Recorded maternal voice for preterm neonates undergoing heel lance. Adv Neonatal Care
  41. (2006). Ohls RK: Erythropoietin concentrations and neurodevelopmental outcome in preterm infants. Pediatrics
  42. (2005). Opioid analgesia in the newborn.
  43. (2000). pain perception, and the extremely low-birth weight survivor. Clin Perinatol
  44. (2002). RD: Effect of recombinant erythropoietin on “late” transfusions in the neonatal intensive care unit: a meta-analysis. J Perinatol
  45. (1996). Recombinant human erythropoietin treatment of anemic cancer patients. Cancer Pract
  46. (2006). RR: Erythropoietin reduces Schwann cell TNF-alpha, Wallerian degeneration and painrelated behaviors after peripheral nerve injury.
  47. (2007). RW: Ketamine reduces the cell death following inflammatory pain in newborn rat brain. Pediatr Res
  48. (1995). Schulte-Hermann R: In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology
  49. (2007). SE: Pharmacokinetics of high-dose recombinant erythropoietin in plasma and brain of neonatal rats. Pediatr Res
  50. (2008). SE: Recent trends in erythropoietin-mediated neuroprotection.
  51. (1977). SG: The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain
  52. (2006). ST: A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery.
  53. (1996). Swaak AJ: Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial. Ann Rheum Dis
  54. (2001). The neurobiology of pain: developmental aspects. Neuroscientist
  55. (2003). Tibboel D: Do we still hurt newborn babies? A prospective study of procedural pain and analgesia in neonates. Arch Pediatr Adolesc Med
  56. (2004). Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke
  57. (2004). Ying-Ju C: Comparison of pain responses of premature infants to the heelstick between containment and swaddling.
  58. (2005). Zhang JH: Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke